So it’s a natural next step that the company, now called Revvity, would get a new headquarters, too. That’s exactly what just happened, with Revvity moving across Route 128 in Waltham to a ...

Revvity (NYSE:RVTY – Free Report) had its price objective cut by Barclays from $140.00 to $135.00 in a research report report published on Monday morning,Benzinga reports. They currently have an ...

Revvity, Inc. (NYSE: RVTY), announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Revvity (RVTY – Research Report), with a price target of $135.00. The company’s shares closed last Friday at ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance ...

Revvity Trading Up 0.4 % NYSE:RVTY opened at $109.91 on Wednesday. The company has a current ratio of 3.56, a quick ratio of 2.97 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 1-year low ...

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in Coral Gables ...

For research use only. Not for use in diagnostic procedures. At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions ...

— We have everything you need: full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; ...